| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040701A2 Non-myeloablative tolerogenic treatment |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040609A1 Novel protein |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040594A1 AcpS |
| 07/13/2000 | WO2000040270A2 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040264A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040261A2 Vaccination method for efficient induction of cytotoxic t lymphocyte response |
| 07/13/2000 | WO2000040260A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | WO2000040089A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 07/13/2000 | WO2000025815A8 Novel immunoadjuvants |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | WO2000018433A3 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
| 07/13/2000 | WO2000015256A3 Immunostimulant emulsion |
| 07/13/2000 | WO2000015175A3 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |
| 07/13/2000 | WO2000014217A3 G-motif oligonucleotides and uses thereof |
| 07/13/2000 | WO2000012128A3 Recombinant subunit vaccine against flaviviral infection |
| 07/13/2000 | WO2000006534A9 Compounds and compositions for delivering active agents |
| 07/13/2000 | WO1999053950A9 Live vaccines and methods of treatment therewith |
| 07/13/2000 | WO1997020575A8 Targeted adenovirus vectors |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | DE19847074C1 Verfahren zum Entfernen von Lipopolysacchariden aus wäßrigen, proteinhaltigen Lösungen A method for removing lipopolysaccharides from aqueous, protein-containing solutions |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2360396A1 Characterization of a calcium channel family |
| 07/13/2000 | CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| 07/13/2000 | CA2358754A1 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | CA2358435A1 Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| 07/13/2000 | CA2358430A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | CA2358427A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | CA2358296A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 07/13/2000 | CA2357996A1 Streptococcal abc transporter protein |
| 07/13/2000 | CA2357677A1 Insulin-synthesis genes |
| 07/13/2000 | CA2356434A1 Non-myeloablative tolerogenic treatment |
| 07/13/2000 | CA2354194A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/12/2000 | EP1018558A2 Hepatitis C Virus Epitopes |
| 07/12/2000 | EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 07/12/2000 | EP1018556A1 Chimeric and/or growth-restricted flaviviruses |
| 07/12/2000 | EP1018555A2 Chimeric papilomavirus-like particles |
| 07/12/2000 | EP1018550A2 Allergenic protein and peptides from house dust mite and uses thereof |
| 07/12/2000 | EP1018548A1 CELLULAR IMMUNOGENICITY POTENTIATING COMPOSITION CONTAINING $g(a)-GLYCOSYLCERAMIDE |
| 07/12/2000 | EP1018518A2 Use of autoantibodies for tumor therapy and prophylaxis |
| 07/12/2000 | EP1018517A2 Binding agents to CD23 for treatment of inflammatory, autoimmune or allergic diseases |
| 07/12/2000 | EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes |
| 07/12/2000 | EP1017840A1 NOVEL $i(SERRATIA MARCESCENS) STRAIN, PRODIGIOSIN AND THE USE OF THE SAME AS AN IMMUNOSUPPRESSIVE |
| 07/12/2000 | EP1017828A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 07/12/2000 | EP1017822A1 $i(LKTA) DELETION MUTANT OF $i(P. HAEMOLYTICA) |
| 07/12/2000 | EP1017818A2 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 07/12/2000 | EP1017815A1 Murine model for human carcinoma |
| 07/12/2000 | EP1017810A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 07/12/2000 | EP1017808A2 53bp2 complexes |
| 07/12/2000 | EP1017807A1 Osf2/cbfa1 compositions and methods of use |
| 07/12/2000 | EP1017806A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 07/12/2000 | EP1017791A1 Recombinant rsv virus expression systems and vaccines |
| 07/12/2000 | EP1017790A1 Methods and compositions for binding hematopoietic stem cells |
| 07/12/2000 | EP1017725A1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |
| 07/12/2000 | EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 07/12/2000 | EP1017720A1 Site-directed chemotherapy of metastases |
| 07/12/2000 | EP1017714A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 07/12/2000 | EP1017420A1 Antigen delivery system |
| 07/12/2000 | EP1017419A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 07/12/2000 | EP1017418A1 Vaccine composition for preventing or treating c hepatitis |
| 07/12/2000 | EP1017417A1 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION FOR USE BY THE SUBDIAPHRAGMATIC SYSTEMIC ROUTE, AND COMBINED MUCOSAL/PARENTERAL IMMUNIZATION METHOD |
| 07/12/2000 | EP1017409A1 Vaccines for chlamydia psittaci infections |
| 07/12/2000 | EP1017402A1 Control of acidic gut syndrome |
| 07/12/2000 | EP1017401A2 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid a |
| 07/12/2000 | EP1017367A1 Methods for fabricating polymer-based controlled release preparions |
| 07/12/2000 | EP1017283A1 Polynucleotide vaccine formulations |
| 07/12/2000 | EP0918545B1 Tumour therapy |
| 07/12/2000 | EP0789754B1 H. pylori fermentation process |
| 07/12/2000 | EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 07/12/2000 | EP0662146B1 Dorsal tissue affecting factor and compositions |
| 07/12/2000 | EP0662000B1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 07/12/2000 | EP0610345B1 Combined cellular and immunosuppressive therapies |
| 07/12/2000 | EP0550553B1 Viral defective vaccine produced by transcomplementing cell line |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1260000A Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 07/12/2000 | CN1259962A Anti-vegf antibodies |
| 07/12/2000 | CN1259961A Humanized antibodies and method for forming same |
| 07/12/2000 | CN1259960A Vaccine compositions comprising the helicobacter pylori FlgE polypeptide |
| 07/12/2000 | CN1259874A Vaginal lactobacillus medicant |
| 07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
| 07/12/2000 | CN1259522A Novel protain from lobar pneumonia Actinomyces |
| 07/11/2000 | US6087479 Introducing into patient a medical device of which at least a portion includes a nitric oxide adduct which may be a sodium nitroprusside, a nitrosothiol, a nitrate, a nitrite or a nitrosated amino acid |
| 07/11/2000 | US6087477 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 07/11/2000 | US6087441 Oligopeptide or polypeptide |
| 07/11/2000 | US6087328 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 07/11/2000 | US6087174 Growth medium for primary pancreatic tumor cell culture |
| 07/11/2000 | US6087170 VZV gene, mutant VZV and immunogenic compositions |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |